Peter Dannenbaum | Vice President of Investor Relations |
Ken Frazier | Chairman & Chief Executive Officer |
Rob Davis | Chief Financial Officer |
Roger Perlmutter | President of Merck Research Labs |
Frank Clyburn | Chief Commercial Officer |
David Risinger | Morgan Stanley |
Chris Schott | JPMorgan |
Tim Anderson | Wolfe Research |
Seamus Fernandez | Guggenheim |
Daina Graybosch | SVB Leerink |
Umer Raffat | Evercore |
Geoff Meacham | Bank of America Merrill Lynch |
Mara Goldstein | Mizuho |
Navin Jacob | UBS |
Steve Scala | Cowen |
Terence Flynn | Goldman Sachs |
Good morning. My name is Jerome, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Company Third Quarter Sales and Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.